Combining the 31-gene expression profile test for cutaneous melanoma with the American Joint Committee on Cancer staging identifies the highest-risk patients with stage I-II disease. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 7, n. 4, p. s223, 2023. DOI: 10.25251/skin.7.supp.223. Disponível em: https://skin.dermsquared.com/skin/article/view/2198. Acesso em: 18 may. 2025.